Eagle Ridge Investment Management Kamada LTD Transaction History

Eagle Ridge Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$5.43 - $6.81 $132,111 - $165,687	-24,330 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$6.3 - $8.46 $57,096 - $76,672	-9,063 Reduced 27.14%	24,330 $158,000
Q2 2020 Jul 29, 2020	SELL	$5.37 - $9.45 $7,303 - $12,851	-1,360 Reduced 3.91%	33,393 $259,000
Q4 2019 Feb 05, 2020	BUY	$4.97 - $7.7 $6,759 - $10,472	1,360 Added 4.07%	34,753 $237,000
Q3 2019 Oct 31, 2019	BUY	$5.11 - $5.99 $170,638 - $200,024	33,393 New	33,393 $171,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $265M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Eagle Ridge Investment Management, based on Form 13F filings with the SEC.

Stay updated on Eagle Ridge Investment Management with notifications on news.